Anna Wancerz
Impact in
-
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Atrial Fibrillation Management and Outcomes
- Cardiac pacing and defibrillation studies
- Cardiomyopathy and Myosin Studies
-
- Galectins and Cancer Biology
- IL-33, ST2, and ILC Pathways
Papers in
-
- Atrial Fibrillation Management and Outcomes 4
- Heart Failure Treatment and Management 2
- Cardiac Arrhythmias and Treatments 1
- Antiplatelet Therapy and Cardiovascular Diseases 1
- Cardiomyopathy and Myosin Studies 1
- Cardiac pacing and defibrillation studies 1
-
- Inflammatory mediators and NSAID effects 1
- Co-authors
- Agnieszka Kapłon‐Cieślicka (7 shared papers)Paweł Balsam (10 shared papers)Agata Tymińska (10 shared papers)Grzegorz Opolski (10 shared papers)Krzysztof Ozierański (10 shared papers)Krzysztof J. Filipiak (7 shared papers)María G. Crespo‐Leiro (6 shared papers)Michał Marchel (6 shared papers)
In The Last Decade
Anna Wancerz
11 papers receiving 97 citations
Peers
Comparison fields: 5 of 23
- Cardiology and Cardiovascular Medicine 60
- Immunology 20
- Endocrinology, Diabetes and Metabolism 10
- Radiology, Nuclear Medicine and Imaging 7
- Nephrology 2
Countries citing papers authored by Anna Wancerz
This map shows the geographic impact of Anna Wancerz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Wancerz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Wancerz more than expected).
Fields of papers citing papers by Anna Wancerz
This network shows the impact of papers produced by Anna Wancerz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Wancerz. The network helps show where Anna Wancerz may publish in the future.
Co-authors
The 23 scholars most cited alongside Anna Wancerz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 33 | |
| 2 | 2019 | 16 | |
| 3 | 2019 | 16 | |
| 4 | 2019 | 15 | |
| 5 | 2018 | 7 | |
| 6 | 2022 | 4 | |
| 7 | 2017 | 4 | |
| 8 | 2020 | 3 | |
| 9 | 2017 | 1 | |
| 10 | 2018 | 1 | |
| 11 | 2017 | 1 |
About Anna Wancerz
Anna Wancerz is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology, Immunology, Infectious Diseases and Organic Chemistry, having authored 11 papers that have together received 101 indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (4 papers), Heart Failure Treatment and Management (2 papers), Galectins and Cancer Biology (1 paper), Cardiac Arrhythmias and Treatments (1 paper), Antiplatelet Therapy and Cardiovascular Diseases (1 paper), Inflammatory mediators and NSAID effects (1 paper), Cardiomyopathy and Myosin Studies (1 paper) and Cardiac pacing and defibrillation studies (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (60 citations), Immunology (20 citations), Endocrinology, Diabetes and Metabolism (10 citations), Radiology, Nuclear Medicine and Imaging (7 citations) and Nephrology (2 citations). Anna Wancerz has collaborated with scholars based in Poland, Italy and Spain. Frequent co-authors include Agnieszka Kapłon‐Cieślicka, Paweł Balsam, Agata Tymińska, Grzegorz Opolski, Krzysztof Ozierański, Krzysztof J. Filipiak, María G. Crespo‐Leiro, Michał Marchel, Michał Peller and Aldo P. Maggioni. Their work appears in journals such as European Heart Journal, Disease Markers, Cardiovascular Drugs and Therapy, Biology and ESC Heart Failure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.